Comparison between Logiciel Solutions IPO and Neochem Bio IPO.
Logiciel Solutions IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Neochem Bio IPO is a SME Bookbuilding proposed to list at NSE SME.
| Logiciel Solutions IPO | Neochem Bio IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Vivro Financial Services Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Logiciel Solutions IPO is up to ₹37.90 Cr whereas the issue size of the Neochem Bio IPO is up to ₹42.69 Cr. The final issue price of Logiciel Solutions IPO is ₹193.00 per share and of Neochem Bio IPO is ₹98.00 per share.
| Logiciel Solutions IPO | Neochem Bio IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹183.00 per share | ₹93.00 per share |
| Issue Price (Upper) | ₹193.00 per share | ₹98.00 per share |
| Issue Price (Final) | ₹193.00 per share | ₹98.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1200 shares |
| Fresh Issue Size | 15,90,600 shares | 43,56,000 shares |
| Fresh Issue Size (Amount) | up to ₹30.70 Cr | up to ₹42.69 Cr |
| OFS Issue Size | 3,73,200 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹7.20 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,63,800 shares | 43,56,000 shares |
| Issue Size Total (Amount) | up to ₹37.90 Cr | up to ₹42.69 Cr |
Logiciel Solutions IPO opens on Nov 28, 2025, while Neochem Bio IPO opens on Dec 02, 2025. The closing date of Logiciel Solutions IPO and Neochem Bio IPO is Dec 02, 2025, and Dec 04, 2025, respectively.
| Logiciel Solutions IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Bid Date | Dec 01, 2025 | |
| Issue Open | Nov 28, 2025 | Dec 02, 2025 |
| Issue Close | Dec 02, 2025 | Dec 04, 2025 |
| Basis Of Allotment (Tentative) | Dec 03, 2025 | Dec 05, 2025 |
| Initiation of Refunds (Tentative) | Dec 04, 2025 | Dec 08, 2025 |
| Credit of Share (Tentative) | Dec 04, 2025 | Dec 08, 2025 |
| Listing date (Tentative) | Dec 05, 2025 | Dec 09, 2025 |
| Anchor Lockin End date 1 | Jan 04, 2026 | |
| Anchor Lockin End date 2 | Mar 05, 2026 |
Logiciel Solutions IPO P/E ratio is 20.35, as compared to Neochem Bio IPO P/E ratio of 15.85.
| Logiciel Solutions IPO | Neochem Bio IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Logiciel Solutions Ltd.'s revenue increased by 24% and profit after tax (PAT) rose by 38% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Neochem Bio Solutions Ltd.'s revenue increased by 39% and profit after tax (PAT) rose by 330% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.78 | 91.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59 | 66.7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 20.35 | 15.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹144.13 Cr. | ₹167.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 32.80% | 48.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 31.95% | 41.67% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.00 | 1.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.48 | ₹6.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.80% | 48.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Logiciel Solutions IPO Retail Individual Investors (RII) are offered 9,34,800 shares while in Neochem Bio IPO retail investors are offered 9,34,800 shares. Qualified Institutional Buyers (QIB) are offered 1,00,200 shares in Logiciel Solutions IPO and 8,71,200 shares in Neochem Bio IPO.
| Logiciel Solutions IPO | Neochem Bio IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 13,03,200 shares |
| Market Maker Reservation | 1,03,800 shares | 2,32,800 shares |
| QIB | 1,00,200 shares | 8,71,200 shares |
| NII | 9,28,800 shares | 6,55,200 shares |
| RII | 9,34,800 shares | 15,26,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 19,63,800 shares | 43,56,000 shares |
Logiciel Solutions IPO subscribed 2.04x in total, whereas Neochem Bio IPO subscribed 15.52x.
| Logiciel Solutions IPO | Neochem Bio IPO | |
|---|---|---|
| QIB (times) | 1.32x | 21.97x |
| NII (times) | 0.73x | 21.15x |
| Big NII (times) | 0.43x | 25.78x |
| Small NII (times) | 1.32x | 11.88x |
| RII (times) | 3.43x | 9.42x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.04x | 15.52x |
